• Human T-Cell Lymphotropic Virus (HTLV) I/II Antibody Screen
  • Urea Nitrogen (BUN) Creatinine Ratio
  • Group A Streptococcus (Streptococcus pyogenes), Molecular Detection, PCR
  • Urea Nitrogen (BUN), Random, Urine
  • Phosphorus (Phosphate), Serum
  • Syphilis, latent
  • FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
  • HLA Class II DR, DQ and DP Genotyping (HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1)
  • Anti-Streptolysin O (ASO)
  • Syphilis, secondary
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
Medical Test

CPT
Access to OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection is restricted.
Loading...